Merck to Boost Next-Decade Revenue Forecast on New-Drug Optimism
Merck plans to raise its revenue forecast for the next decade, citing optimism about new drugs.
Related stories
Daito Trust Construction Reports Six-Month Group Net Profit Growth
The company forecast higher profit for 2026/27.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC
Daito Trust Construction Reports Six-Month Recurring Profit Up 10.1%
The company forecasts 2026/27 profit growth of 6.3%.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC
Daito Trust Construction 6-Month Operating Profit Rises 14.3%
The company forecasts 2026/27 profit, up 10.9%.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC
Inaba Denki Sangyo Reports 6-Month Net Profit Up 35.0%
Group net profit rose 35.0%; the company forecasts 2026/27 profit up 15.3%.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC
Inaba Denki Sangyo Revises 2026/27 Group Recurring Profit Forecast
The company revised its 2026/27 group recurring profit forecast upward by 13.4%.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC
Daiwa Securities Group Reports Midyear Operating Profit of 1484.27 Hundred Million Yen, Up 72.5%
Daiwa Securities Group reported consolidated operating profit of 1484.27 hundred million yen for the six months ended September, up 72.5%.
M impact | EARNINGS | Oct 30, 2026, 02:31 AM UTC